{
  "company": {
    "name": "Doloromics",
    "website": "https://doloromics.com/",
    "record": "https://startuphistory.org/c/doloromics.com"
  },
  "status": null,
  "history_since": "2021-07-23T23:26:04.000Z",
  "baseline": {
    "snapshot_id": "69297deff0b681a8c7f4c2883188c7fb7bc306b04794cd50a29adab1e4d28216",
    "observed_at": "2021-07-23T23:26:04.000Z",
    "headline": "Doloromics | Chronic Pain",
    "description": "Doloromics finds novel ways to treat chronic pain through genomic analysis",
    "evidence": "https://web.archive.org/web/20210723232604/https://www.doloromics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [
    {
      "quote_observed_at": "2023-06-05T01:08:35.000Z",
      "variants": [
        {
          "headline": "Doloromics | Chronic Pain",
          "subhead": "Doloromics finds novel ways to treat chronic pain through genomic analysis",
          "observed_at": "2021-07-23T23:26:04.000Z",
          "evidence": "https://web.archive.org/web/20210723232604/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doloromics | Chronic Pain",
          "subhead": "Doloromics finds novel ways to treat chronic pain through genomic analysis",
          "observed_at": "2022-01-13T17:00:45.000Z",
          "evidence": "https://web.archive.org/web/20220113170045/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doloromics | Chronic Pain",
          "subhead": "Doloromics finds novel ways to treat chronic pain through genomic analysis",
          "observed_at": "2022-07-04T13:06:49.000Z",
          "evidence": "https://web.archive.org/web/20220704130649/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doloromics | Precision Medicines for Chronic Pain",
          "subhead": "Bringing disease-modifying, precision treatments to patients that are underserved by the status quo.",
          "observed_at": "2023-06-05T01:08:35.000Z",
          "evidence": "https://web.archive.org/web/20230605010835/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Doloromics | Precision Medicines for Chronic Pain",
      "subhead": "Bringing disease-modifying, precision treatments to patients that are underserved by the status quo.",
      "from": "2021-07-23T23:26:04.000Z",
      "to": "2023-06-05T01:08:35.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20230605010835/https://www.doloromics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-07-23T23:26:04.000Z",
          "to": "2023-06-05T01:08:35.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-02-25T00:06:08.000Z",
      "variants": [
        {
          "headline": "Dedicated to curing pain",
          "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
          "observed_at": "2023-10-31T01:07:58.000Z",
          "evidence": "https://web.archive.org/web/20231031010758/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Dedicated to curing pain",
          "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
          "observed_at": "2024-02-25T00:06:08.000Z",
          "evidence": "https://web.archive.org/web/20240225000608/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Dedicated to curing pain",
      "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
      "from": "2023-10-31T01:07:58.000Z",
      "to": "2024-02-25T00:06:08.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20240225000608/https://www.doloromics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-10-31T01:07:58.000Z",
          "to": "2024-02-25T00:06:08.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-03-04T02:42:35.000Z",
      "variants": [
        {
          "headline": "Precision Neuropharmaceuticals ‍ Targeted Relief",
          "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
          "observed_at": "2024-09-28T05:13:37.000Z",
          "evidence": "https://web.archive.org/web/20240928051337/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Precision Neuropharmaceuticals ‍ Targeted Relief",
          "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
          "observed_at": "2025-01-15T02:14:02.000Z",
          "evidence": "https://web.archive.org/web/20250115021402/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Precision Neuropharmaceuticals ‍ Targeted Relief",
          "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
          "observed_at": "2025-03-04T02:42:35.000Z",
          "evidence": "https://web.archive.org/web/20250304024235/https://www.doloromics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Precision Neuropharmaceuticals ‍ Targeted Relief",
      "subhead": "Capitalizing on our ground-breaking human-to-human target identification and validation platform, we're redefining the landscape of pain management",
      "from": "2024-09-28T05:13:37.000Z",
      "to": "2025-03-04T02:42:35.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20250304024235/https://www.doloromics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-09-28T05:13:37.000Z",
          "to": "2025-03-04T02:42:35.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-1344ecd6e09cdae662a98a394613bf08720e9b84d0dfe91a02b7a45e742b8a0f:ba93b8e966c0fec220b2643f01762cffc9dd99eac7ff8cc3590c7fe52df88998:headline:1a0fcf79a6306aba",
      "before_evidence": "https://web.archive.org/web/20240225000608/https://www.doloromics.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Dedicated to curing pain” to “Precision Neuropharmaceuticals ‍ Targeted Relief”.",
      "between": {
        "from": "2024-02-25T00:06:08.000Z",
        "to": "2024-09-28T05:13:37.000Z"
      },
      "evidence": "https://web.archive.org/web/20240928051337/https://www.doloromics.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Doloromics” company record, https://startuphistory.org/c/doloromics.com"
}